Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.42
+0.02 (0.31%)
Nov 13, 2026, 4:00 PM EST - Market closed

Lifecore Biomedical Revenue

Lifecore Biomedical had revenue of $25.32M in the quarter ending September 30, 2026, a decrease of -18.60%. This brings the company's total for the last twelve months to $119.13M, down -8.58% year-over-year. In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth. That makes Lifecore Biomedical the 22,211th largest company in the world by revenue and 3,249th in the United States.

Revenue (ttm)
$119.13M
Revenue Growth
-8.58%
P/S Ratio
2.28
Revenue / Employee
$278,693
Employees
382
Market Cap
243.36M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
May 25, 2025128.87M606.00K0.47%
May 26, 2024128.26M24.99M24.20%
May 28, 2023103.27M-8.00M-7.19%
May 29, 2022111.27M10.40M10.31%
May 30, 2021100.87M-59.19M-36.98%
May 31, 2020160.07M-397.49M-71.29%
May 26, 2019557.56M33.33M6.36%
May 27, 2018524.23M54.45M11.59%
May 28, 2017469.78M-7.14M-1.50%
May 29, 2016476.92M-62.34M-11.56%
May 31, 2015539.26M62.44M13.10%
May 25, 2014476.81M35.11M7.95%
May 26, 2013441.71M124.16M39.10%
May 27, 2012317.55M40.82M14.75%
May 29, 2011276.73M44.64M19.23%
May 30, 2010232.09M3.54M1.55%
May 31, 2009228.55M-2.64M-1.14%
May 25, 2008231.19M25.76M12.54%
May 27, 2007205.43M-23.70M-10.34%
May 28, 2006229.13M24.41M11.92%
May 29, 2005204.72M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Tilray Brands963.10M
Emergent BioSolutions649.10M
Evolus325.47M
Aurora Cannabis221.16M
Canopy Growth217.18M
Akebia Therapeutics197.20M
Kamada196.87M
Anika Therapeutics123.43M
Revenue Rankings